Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron.
Nucletron expands exec ranks
Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron. As vice president of global marketing, Jan Boers will be responsible for worldwide marketing and communications, joining the firm after serving in roles at CSM Food, Heinz, and Sara Lee International. John Lapré takes over as Nucletron's vice president of research and development following his most recent stint as VP of research and development for CP Kelco. Bringing nearly 20 years of international experience in the pharmaceutical industry, Dr. Jonathan Briers leads the company’s newly created medical affairs department, having served in product management and medical affairs at Servier International, SmithKline Beecham and, most recently, at Pfizer. Briers previously held appointments at the University of Manchester Medical School in the U.K. and clinical posts in Manchester and Liverpool.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.